Clinical and echocardiographic features of children with rheumatic carditis: correlation with high sensitivity C-reactive protein.
DOI:
https://doi.org/10.52981/sjms.v8i3.905Keywords:
Rheumatic carditis, C-reactive proteinAbstract
Background: Rheumatic fever (RF) and rheumatic heart disease (RHD) are leading causes of cardiovascular mortality and morbidity in developing countries.
Objectives: To describe the clinical and echocardiographic features of children with RF and RHD and compare these features with their serum C-reactive protein in 2 pediatric cardiology centers in Khartoum.
Methodology: It was a prospective cross sectional study. Patients were examined clinically and by echocardiography. Serum high sensitivity C-reactive protein (hsCRP) was measured from children with Acute RF as well as from healthy age and sex matched controls selected from children attending the clinics. Statistical Analysis Used: Mean and standard deviation, P value using Fisher’s exact test.
Results: Sixty six patients (45% males) were enrolled. Mitral regurgitation (MR) was found in 65 patients (98%), it was severe in 42 patients (64%), combined with aortic regurgitation (AR) in 27 patients (41%) and with Mitral stenosis (MS) in 3 patients (4.5%). For patients with carditis, hsCRP ranged between 1.10 and 15 mg/l (mean 8.0817, SD 4.47). In the control group it was 0.6-1.3 mg/l (mean 0.93 SD 0.23) P<0.0001.Patients with Acute RF had hsCRP mean of 12.35 mg/l (SD 2.11) while those with chronic RHD had hsCRP mean of 7.34 mg/l (SD 4.16), P<0.0001.
Conclusion: RHD is manifested in our patients with severe valve damage dominated by MR and there is evidence of an ongoing inflammation during the chronic phase. RHD is manifested in a severe form in Sudan. High sensitivity CRP is elevated in acute phase as well as in the chronic phase
References
2. Ibrahim -Khalil S, Elhag M, Ali E, Mahgoub F, Hakiem S et al. An epidemiological survey of rheumatic fever and rheumatic heart disease in Sahafa Town, Sudan Epidemiol Community Health 1992;46:477-9.
3. Habeeb NM, Al Hadidi IS.Ongoing inflammation in children with rheumatic heart disease. Cardiol Young 2011:334-9.
4. Bo Reményi, Nigel Wilson, Andrew Steer, Beatriz Ferreira, Joseph Kado et al. World Heart Federation criteria for echocardiographic diagnosis of rheumatic heart disease—an evidence-based guideline. Nat Rev Cardiol. 2012; 9(5):297-309.
5. Ganesan Karthikeyan, , Bongani M. Mayosi. Primary Prevention of Rheumatic Fever the Missing Link in the Control of Rheumatic Heart Disease in Africa Circulation 2009;120:709-713.
6. M.S. Alkhalifa, S.A. Ibrahim and S.H. Osman. Pattern and severity of rheumatic valvular lesions in children in Khartoum, Sudan. Eastern Mediterranean Health Journal 2008; 14: 29-. 35.
7. Sulafa KM Ali, Z Karani. Diagnosis, Management & Outcome of Children with Heart Disease in a Sudanese Cardiac Center. East African Med J 2007; 9:434-440.
8. Chockalingam A, Gnanavelu G, Elangovan S, Chockalingam V. Clinical spectrum of chronic rheumatic heart disease in India. J Heart Valve Dis. 2003; 12:577-81.
9. Gölbasi Z, Uçar O, Keles T, Sahin A, Cagli K, Camsari A, Diker E, Aydogdu S. Increased levels of high sensitive C-reactive protein in patients with chronic rheumatic valve disease: evidence of ongoing inflammation. Eur J Heart Fail. 2002; 4:593-5.
10. Sulafa Khalid Mohamed Ali, Inaam Noor Eldaim, Samia Hassan Osman, Sahar Mohamed Bakhite. Clinical and echocardiographic features of children with rheumatic heart disease and their serum cytokine profile.The Pan African Medical Journal 2012;13:36.